Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia

• Status: Unknown status
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a follow-up study to investigate the long-term safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs), for the treatment of BPD in premature infants. Subjects who participated in and completed the initial stage of the PhaseⅠtrial (NCT03558334 ) will be followed-up until 48 months after the hUC-MSCs transplantation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Hospital of Chongqing Medical University

Criteria

Inclusion Criteria:

1. Subject who completed the safety and efficacy evaluations in hUC-MSCs PhaseⅠ clinical trial

2. Subject with a written consent form signed by a legal representative or a parent

Exclusion Criteria:

1. Subject whose parent or legal representative does not agree to participate in the study

2. subject who is considered inappropriate to participate the study by the investigator